Table 1.
Day of therapy of each category of intravenous antimicrobials in the tertiary care hospital and the community hospital between April 2021 and March 2022.
Table 2.
Day of therapy (DOT) in each broad-spectrum antibiotic predominantly used for hospital-onset infections, and antibiotic heterogeneity indices (AHIs) for this category antibiotics in the tertiary care hospital and community hospital.
Fig 1.
Resistant rate according to the European Committee on Antimicrobial Susceptibility Testing criteria in nosocomial isolates of Gram-negative rods (GNRs), glucose-non-fermenting GNRs and Enterobacteriaceae species between the tertiary care hospital and community hospital.
Table 3.
Resistant rate according to the European Committee on Antimicrobial Susceptibility Testing criteria and beta-lactamase-producing rate in each organism in the tertiary care hospital and community hospital.
Fig 2.
Change of antibiotic use of broad-spectrum antibiotics before and after a new antimicrobial stewardship (AS) team in the community hospital.
DDD: defined daily dose; DOT: day of therapy. Grey bar showed mean monthly DDD and black bar showed mean monthly DOT during the corresponding period.
Table 4.
Defined daily dose (DDD) of each broad-spectrum antibiotic commonly used for hospital-onset infections and the antibiotic heterogeneity indices (AHIs) before and after establishment of a new antimicrobial stewardship (AS) team in the community hospital.
Fig 3.
Relative day of therapy of each broad-spectrum antibiotic commonly used for hospital-onset infections in term 1 and term 2 after establishment of a new antibiotic stewardship team in the community hospital.
Gray bar shows DOT in term 1 and black bar shows DOT in term 2.
Table 5.
Antibiotic heterogeneity indices (AHIs) in term 1 and term 2 after the establishment of a new antibiotic stewardship team in the community hospital.